ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
DNA Nanoarray for Multiplexed RNA Detection With Single-Molecule Readout.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanopore-Based Profiling of PEGylation in Nucleic Acid Therapeutics.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Sensitive and multiplexed RNA analysis at the single-molecule level remains a key challenge in molecular diagnostics. Conventional fluorescence microarrays provide high throughput but lack molecular resolution, whereas single-molecule sensors such as nanopores offer exquisite precision but limited scalability. Here, we present a DNA carrier-based nanoarray that integrates programmable nucleic acid hybridization with solid-state nanopore readout for direct, multiplexed RNA detection. Each modular DNA carrier is pre-assembled with spatially defined probe sites that sequence-specifically capture RNA targets of varying lengths and conformations, in which poly(dT) sequences both structurally facilitate target binding and enhance signal strength without the need for fluorescent or protein labeling. Upon nanopore translocation, hybridized carrier-target complexes generate binary ionic current signatures, allowing single-molecule identification of target occupancy at each sensing site. Using a ternary coordinate encoding system, we constructed a nanoarray comprising 27 carriers with 81 addressable sensing sites, enabling simultaneous detection of multiple bacterial and viral RNA targets within a single assay directly from total RNA extracts without target-specific isolation, amplification, or enrichment. By combining the multiplexing capability of traditional microarrays with the single-molecule precision of nanopore sensing, this carrier-based nanoarray establishes a scalable, programmable, and universally adaptable framework for high-throughput molecular diagnostics in complex biological backgrounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.